For example, GLP-1 receptor agonists may be more efficacious than SGLT2 inhibitors in preventing stroke [32, 33], appear to be efficacious in youth with young-onset diabetes [34], and may be more efficacious in Chinese and other Asian populations relative to European populations [35]. The gene discussed is SLC5A2; the disease is Stroke.